Innovotech Inc IOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.10
- Day Range
- CAD 0.12–0.12
- 52-Week Range
- CAD 0.06–0.13
- Bid/Ask
- CAD 0.08 / CAD 0.15
- Market Cap
- CAD 4.68 Mil
- Volume/Avg
- 5,500 / 5,018
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.97
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Innovotech Inc is a Canada-based company that provides solutions to client biofilm problems through its biofilm contract research department. The core activities of the company are sales of its products, conducting contract research for outside customers, and research and development to identify products for future commercialization. The products of the company include human and fungal biofilm susceptibility tests, a seed treatment designed to combat bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. Geographically, the firm has a business presence in the United States, Canada, and the Rest of the world of which the majority of the revenue is derived from the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 14
- Website
- https://www.innovotech.ca
Valuation
Metric
|
IOT
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.07 |
Price/Sales | 3.97 |
Price/Cash Flow | — |
Price/Earnings
IOT
Financial Strength
Metric
|
IOT
|
---|---|
Quick Ratio | 2.62 |
Current Ratio | 3.22 |
Interest Coverage | −304.81 |
Quick Ratio
IOT
Profitability
Metric
|
IOT
|
---|---|
Return on Assets (Normalized) | −29.75% |
Return on Equity (Normalized) | −41.01% |
Return on Invested Capital (Normalized) | −34.47% |
Return on Assets
IOT
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jswskmnt | Wlq | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Ymjjkpjj | Gkmjwj | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Vmtcyqwn | Xtkdtc | $108.2 Bil | |
MRNA
| Moderna Inc | Vwyhjxmz | Xjjz | $54.0 Bil | |
BNTX
| BioNTech SE ADR | Rcnpcsqxr | Qjfr | $21.8 Bil | |
ARGX
| argenx SE ADR | Fnhvnvjp | Rxpnm | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Cflycbtrk | Xytxl | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Lgfnkytn | Zxrsbb | $14.6 Bil | |
INCY
| Incyte Corp | Ltpxnctbv | Wgsczq | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Mnjggjrvwv | Clkss | $12.3 Bil |